322 related articles for article (PubMed ID: 31043069)
1. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.
Pacífico de Carvalho N; Mendicino CCP; Cândido RCF; Alecrim DJD; Menezes de Pádua CA
AIDS Care; 2019 Oct; 31(10):1234-1240. PubMed ID: 31043069
[TBL] [Abstract][Full Text] [Related]
2. Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
Hoagland B; De Boni RB; Moreira RI; Madruga JV; Kallas EG; Goulart SP; Cerqueira N; Torres TS; Luz PM; Fernandes NM; Liu AY; Grinsztejn B; Veloso VG;
AIDS Behav; 2017 May; 21(5):1278-1287. PubMed ID: 27531461
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
[TBL] [Abstract][Full Text] [Related]
4. Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.
Yan L; Yan Z; Wilson E; Arayasirikul S; Lin J; Yan H; McFarland W
AIDS Behav; 2021 Mar; 25(3):866-874. PubMed ID: 32989576
[TBL] [Abstract][Full Text] [Related]
5. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Sevelius JM; Keatley J; Calma N; Arnold E
Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
[TBL] [Abstract][Full Text] [Related]
6. Pre-Exposure Prophylaxis in Trans Populations: Providing Gender-Affirming Prevention for Trans People at High Risk of Acquiring HIV.
Deutsch MB
LGBT Health; 2018 Oct; 5(7):387-390. PubMed ID: 30272493
[TBL] [Abstract][Full Text] [Related]
7. Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
Uthappa CK; Allam RR; Pant R; Pal S; Dinaker M; Oruganti G; Yeldandi VV
HIV Med; 2018 Apr; 19(4):243-251. PubMed ID: 29178158
[TBL] [Abstract][Full Text] [Related]
8. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
[TBL] [Abstract][Full Text] [Related]
9. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
[TBL] [Abstract][Full Text] [Related]
10. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.
Yi S; Tuot S; Mwai GW; Ngin C; Chhim K; Pal K; Igbinedion E; Holland P; Choub SC; Mburu G
J Int AIDS Soc; 2017 Jun; 20(1):21580. PubMed ID: 28691439
[TBL] [Abstract][Full Text] [Related]
11. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.
Golub SA; Gamarel KE; Rendina HJ; Surace A; Lelutiu-Weinberger CL
AIDS Patient Care STDS; 2013 Apr; 27(4):248-54. PubMed ID: 23565928
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
[TBL] [Abstract][Full Text] [Related]
13. Geographic and Individual Associations with PrEP Stigma: Results from the RADAR Cohort of Diverse Young Men Who have Sex with Men and Transgender Women.
Mustanski B; Ryan DT; Hayford C; Phillips G; Newcomb ME; Smith JD
AIDS Behav; 2018 Sep; 22(9):3044-3056. PubMed ID: 29789985
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of Daily Use of Free Oral Pre-exposure Prophylaxis (PrEP) Among Transgender Women Sex Workers in Shenyang, China.
Wang Z; Lau JTF; Yang X; Cai Y; Gross DL; Ma T; Liu Y
AIDS Behav; 2017 Dec; 21(12):3287-3298. PubMed ID: 28752354
[TBL] [Abstract][Full Text] [Related]
15. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
[TBL] [Abstract][Full Text] [Related]
16. Facilitators and Barriers to Participation in PrEP HIV Prevention Trials Involving Transgender Male and Female Adolescents and Emerging Adults.
Fisher CB; Fried AL; Desmond M; Macapagal K; Mustanski B
AIDS Educ Prev; 2017 Jun; 29(3):205-217. PubMed ID: 28650227
[TBL] [Abstract][Full Text] [Related]
17. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
18. Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.
Iniesta C; Álvarez-Del Arco D; García-Sousa LM; Alejos B; Díaz A; Sanz N; Garrido J; Meulbroek M; Pujol F; Moreno S; Fuster-Ruiz de Apocada MJ; Coll P; Antela A; Del Romero J; Ayerdi O; Riera M; Hernández J; Del Amo J
PLoS One; 2018; 13(10):e0204738. PubMed ID: 30339690
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of Antiretroviral Pre-exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities.
Restar AJ; Kuhns L; Reisner SL; Ogunbajo A; Garofalo R; Mimiaga MJ
AIDS Behav; 2018 Nov; 22(11):3649-3657. PubMed ID: 29713838
[TBL] [Abstract][Full Text] [Related]
20. HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.
Oldenburg CE; Le B; Toan T; Thien DD; Huyen HT; Friedman MR; Stall R; Colby D
AIDS Behav; 2016 Dec; 20(Suppl 3):365-370. PubMed ID: 27435073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
